General Nephrology – Other

G TESCH1,2,  N PULLEN3, D NIKOLIC-PATERSON1,2 1Monash Health, Australia, 2Monash University Centre for Inflammatory Diseases, Clayton, Australia, 3Pfizer Worldwide Research & Development, Cambridge, USA Aim: To evaluate intervention with a CCR2 antagonist (CCR2A) in a model of progressive diabetic glomerulosclerosis...
Recent Comments
    Categories